Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2
出版年份 2020 全文链接
标题
Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2
作者
关键词
-
出版物
Epigenomics
Volume 12, Issue 15, Pages 1349-1361
出版商
Future Medicine Ltd
发表日期
2020-09-02
DOI
10.2217/epi-2020-0162
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Potential interventions for novel coronavirus in China: A systematic review
- (2020) Lei Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis
- (2019) Scott D. Solomon et al. CIRCULATION
- Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
- (2019) Eliane Sardh et al. NEW ENGLAND JOURNAL OF MEDICINE
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
- (2019) Wen Shen et al. NATURE BIOTECHNOLOGY
- Strategies for Zika drug discovery
- (2019) Jing Zou et al. Current Opinion in Virology
- Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses
- (2019) Venice Du Pont et al. Current Opinion in Virology
- Current status of small molecule drug development for Ebola virus and other filoviruses
- (2019) Megan R Edwards et al. Current Opinion in Virology
- Nucleoside analogues for the treatment of coronavirus infections
- (2019) Andrea J Pruijssers et al. Current Opinion in Virology
- Editorial overview: Antiviral strategies: Antiviral drug development for single-stranded RNA viruses
- (2019) Margo A Brinton et al. Current Opinion in Virology
- Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges
- (2019) Chandrashekhar Voshavar CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy
- (2019) Lindsay N. Alfano et al. MEDICINE
- Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome
- (2018) Nancy A. Kernan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program
- (2018) Nancy A. Kernan et al. PEDIATRIC BLOOD & CANCER
- Structural and functional conservation of cis -acting RNA elements in coronavirus 5'-terminal genome regions
- (2018) Ramakanth Madhugiri et al. VIROLOGY
- Chemical Modification Study of Antisense Gapmers
- (2018) Robert Stanton et al. Nucleic Acid Therapeutics
- RNA Interference as a Prospective Tool for the Control of Human Viral Infections
- (2018) Alesia Levanova et al. Frontiers in Microbiology
- Self-Replicating RNA Viruses for RNA Therapeutics
- (2018) Kenneth Lundstrom MOLECULES
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
- (2017) Naoki Iwamoto et al. NATURE BIOTECHNOLOGY
- Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
- (2017) Xiulong Shen et al. NUCLEIC ACIDS RESEARCH
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- Viruses and miRNAs: More Friends than Foes
- (2017) Patrice Bruscella et al. Frontiers in Microbiology
- Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
- (2016) P. G. Richardson et al. BLOOD
- Self-replicating RNA viral vectors in vaccine development and gene therapy
- (2016) Kenneth Lundstrom Future Virology
- Pediatric experience with mipomersen as adjunctive therapy for homozygous familial hypercholesterolemia
- (2016) Frederick J. Raal et al. Journal of Clinical Lipidology
- Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia
- (2016) P. Barton Duell et al. Journal of Clinical Lipidology
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma
- (2016) Stephan Grabbe et al. Nanomedicine
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Distribution of miRNA expression across human tissues
- (2016) Nicole Ludwig et al. NUCLEIC ACIDS RESEARCH
- Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates
- (2016) John T. Bates et al. VACCINE
- Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study
- (2015) Ole B Suhr et al. Orphanet Journal of Rare Diseases
- The structure and functions of coronavirus genomic 3′ and 5′ ends
- (2015) Dong Yang et al. VIRUS RESEARCH
- RNA Viruses and RNAi: Quasispecies Implications for Viral Escape
- (2015) John Presloid et al. Viruses-Basel
- Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study
- (2014) David S Boyer et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Dendritic Cell-Targeted Vaccines
- (2014) Lillian Cohn et al. Frontiers in Immunology
- Acute Kidney Injury During Therapy With an Antisense Oligonucleotide Directed Against PCSK9
- (2013) Eveline P. van Poelgeest et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Binding of the 5'-untranslated region of coronavirus RNA to zinc finger CCHC-type and RNA-binding motif 1 enhances viral replication and transcription
- (2012) Y. W. Tan et al. NUCLEIC ACIDS RESEARCH
- INTRAVITREAL PEGAPTANIB SODIUM (MACUGEN) FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
- (2012) Michele Rinaldi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Selection, Optimization, and Pharmacokinetic Properties of a Novel, Potent Antiviral Locked Nucleic Acid-Based Antisense Oligomer Targeting Hepatitis C Virus Internal Ribosome Entry Site
- (2011) Carl Laxton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex
- (2011) E. S. Machlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small Interfering RNA Effectively Inhibits the Expression of SARS Coronavirus Membrane Gene at Two Novel Targeting Sites
- (2010) Ying Wang et al. MOLECULES
- Design of LNA-modified siRNAs against the highly structured 5′ UTR of coxsackievirus B3
- (2008) Mariola Dutkiewicz et al. FEBS LETTERS
- Structural Lability in Stem–Loop 1 Drives a 5′ UTR–3′ UTR Interaction in Coronavirus Replication
- (2008) Lichun Li et al. JOURNAL OF MOLECULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started